Case report of a fatal intoxication by Nucynta. 2014

Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
From the *Office of the Armed Forces Medical Examiner, Rockville; †Office of the Chief Medical Examiner, State of Maryland, Baltimore, MD; and ‡NMS Labs, Willow Grove, PA.

Tapentadol (Nucynta) is a centrally acting opioid analgesic prescribed for the treatment of moderate to severe acute pain. Its efficacy is believed to be due to μ-opioid receptor agonist activity and inhibition of norepinephrine reuptake resulting in increased norepinephrine concentrations. There is only one other case in the literature relating to the toxicity of this agent or report of a fatality. This case report documents a case in which tapentadol was identified as the cause of death. The tapentadol concentration found in the heart blood submitted in this case was more than 20 times the upper limit of the therapeutic range. Possible mechanisms of death include respiratory depression, central nervous system depression, and serotonin syndrome. Based on the scene investigation and autopsy findings in this case, the medical examiner determined that the cause of death was narcotic (Nucynta) intoxication and the manner of death was undetermined.

UI MeSH Term Description Entries
D008297 Male Males
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077432 Tapentadol An opioid analgesic, MU OPIOID RECEPTOR agonist, and noradrenaline reuptake inhibitor that is used in the treatment of moderate to severe pain, and of pain associated with DIABETIC NEUROPATHIES. 3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)phenol,Nucynta,Tapentadol Hydrochloride
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal
D062787 Drug Overdose Accidental or deliberate use of a medication or street drug in excess of normal dosage. Drug Overdoses,Overdose, Drug,Overdoses, Drug

Related Publications

Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
December 2005, The American journal of forensic medicine and pathology,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
January 1984, International archives of occupational and environmental health,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
January 2013, Journal of analytical toxicology,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
November 2002, Annales de medecine interne,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
February 1979, The New England journal of medicine,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
January 1975, Medicine, science, and the law,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
July 2022, Klinische Padiatrie,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
January 2018, Journal of community hospital internal medicine perspectives,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
September 2021, Klinische Padiatrie,
Dori M Franco, and Zabiullah Ali, and Barry Levine, and Robert A Middleberg, and David R Fowler
June 2020, Forensic science international,
Copied contents to your clipboard!